// Title
// Journal
// Nr.
Projection of CKD prevalence in Europe up to 2025
NDT 2015
30 (suppl 4):iv113-iv118
30 (suppl 4):iv113-iv118
R 52
Loss of function
GFR slope
Waiting Time for Second Kidney Transplantation and Mortality
CJASN 2021
17(1):90-97
17(1):90-97
170
Predicting donor, recipient and graft survival in living donor kidney transplantation to inform pre-transplant counseling: the donor and recipient linked iPREDICTLIVING tool
Transplant Int 2020
33(7):729-739
33(7):729-739
158
Management of ESRD in elderly patients
PLOS ONE 2017
12(7):e0181345
12(7):e0181345
139
Design and Implementation of the International Genetics & Translational Research in Transplantation Network (iGeneTRAIN)
Transplantation 2015
99(11):2401-12
99(11):2401-12
127
Risk Calculator
CJASN 2015
10(8):1371-1379
10(8):1371-1379
124
Molecular pathogenesis of post-transplant Acute Kidney Injury: assessment of whole-genome mRNA and miRNA profiles
PLOS ONE 2014
9(8):e104164
9(8):e104164
115
Left atrial diameter and survival among renal allograft recipients.
CJASN 2013
8:2100-2105
8:2100-2105
114
Diet and Kidney Disease in High Risk Individuals with Type 2 Diabetes
JAMA Int Med 2013
173(18):1682-92
173(18):1682-92
112
miRNA profiling discriminates types of rejection and injury in human renal allografts.
Transplantation 2013
95:835-841
95:835-841
111
Synthetic lethality for linking Mycophenolate Mofetil mode of action with molecular disease and drug profiles.
Mol BioSystems 2012 8(12):3197-3207
110
Sirolimus induced phosphaturia is not caused by inhibition of renal apical sodium phosphate cotransporters.
PLOS ONE 2012 7(7):e39229
109
Cost-effectiveness Analysis of Renal Replacement Therapy in Austria.
Nephrol Dial Transplant 2011 26(9):2988-95
99
Steroid donor pretreatment to prevent postischemic renal allograft failure: a randomised, controlled trial.
Ann Int Med 2010
153:222-230
153:222-230
97
Molecular biomarker candidates of acute kidney injury in zero-hour renal transplant needle biopsies.
Transpl Int 2011 24:143-149
96
Association of ESA hypo-responsiveness and haemoglobin variability with mortality in hemodialysis patients.
Nephrol Dial Transplant 2010 25:3701-3706
95
Impaired metabolism in donor kidney grafts after steroid pretreatment.
Transplantation Int 2010 23:796-804
93
Glucose control is associated with patient and graft survival in diabetic patients after renal transplantation.
Transplantation 2010 89:612-619
91
Biocompatibility of Peritoneal Dialysis Solutions Determined by Genomics of Human Leukocytes: A Cross-over study.
Nephrol Dial Transplant plus 2009 2:510-512
90
Hemoglobin levels above 12.5 g/dl achieved by erythropoietin stimulating agents in renal transplant recipients are associated with elevated mortality: a cohort study.
BMJ 2009 339:b4018
88
Antithymocyte globulin use for treatment of biopsy confirmed acute rejection is associated with prolonged renal allograft survival.
Transplantation Int 2010 23:64-70
87
Mycophenolate Mofetil use is associated with prolonged graft survival after kidney transplantation.
Transplantation 2009 88:1095-1100
86
Calcineurin inhibitor based immunosuppressive therapy, organ donor age and long term outcome after transplantation An analysis of interactions and associations.
Transplantation 2009 87: 1821-1829
85
Body mass index modifies the risk of cardiovascular death in proteinuric chronic kidney disease.
Nephrol Dial Transplant 2009 24:2421–2428
84
Gene expression in Passive Heymann Nephritis.
Nephron Exp Nephrol 2009 112:43-58
82
Molecular predictors of anaemia after kidney transplantation.
Nephrol Dial Transplant 2009 24:1015-1023
80
Histogenomics: Association of gene expression patterns with histological parameters in kidney biopsies.
Transplantation 2009 87:290-295
79
Biocompatibility of Hemodialysis Membranes Determined by Differential Gene Expression Analysis of Human Leukocytes: A randomized Cross-over Study.
Eur J Clin Invest 2008 38:918-924
77
Statin use is associated with prolonged survival of renal transplant recipients.
JASN 2008 19:2211-2218
74
ACE-Inhibitor or AT2-Antagonist therapy of renal transplant recipients is associated with an increase in serum potassium concentrations.
Nephrol Dial Transplant 2008 23:1742-1746
70
Gene-expression profiles and age of donor kidney biopsies obtained before transplantation distinguish medium term graft function.
Transplantation 2007 83:1048-1054
65
The Association between ACE Inhibitor or Angiotensin Receptor Blocker Use during Postischemic Acute Transplant Failure and Renal Allograft Survival.
Transplantation 2006 82:1441-1448
61
Molecular signature of mice T lymphocytes following tolerance induction by allogeneic BMT and CD40-CD40L costimulation blockade.
Transpl Int. 2006 19:146-157
56
Angiotensin-converting enzyme inhibitor or AT1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
J Am Soc Nephrol 2006 17:889-899
54
Transcriptional response in the unaffected kidney after contralateral hydronephrosis or nephrectomy.
Kidney Int 2005 68:2497-2507
52
Detection of coregulation in differential gene expression profiles.
BioSystems 2005 82:235-247
51
Alterations in gene expression in cadaveric vs live donor kidneys suggest impaired tubular counterbalance of oxidative stress at implantation.
Am J Transplant 2004 4:1595-1604
48
Genome wide gene expression patterns of donor kidney biopsies distinguish primary allograft function
Lab Invest 2004 84:353-361
45